Together, never by the surgeon alone.
Improving OS, however, remains a challenge in this disease.
Children's Oncology Group A3973 analysis, Journal of Clinical Oncology, 2017
These findings support continued attempts at ≥ 90% resection of the primary tumor in high-risk neuroblastoma.
Children's Oncology Group A3973 analysis, Journal of Clinical Oncology, 2017
What does the evidence show for neuroblastoma and Wilms tumor?
Two cancers, two surgical goals.
In Wilms tumor the surgeon removes the whole kidney with the tumor intact, since spillage changes the treatment. In neuroblastoma the surgeon aims for the most complete removal that leaves the vessels, kidneys and nerves safe, and a small remnant is acceptable where taking it would harm the child. Large international trials have shaped both approaches, and the results below come from the groups that run them.
Cardiotoxic effects were reported in 15 (5%) of 291 children receiving treatment including doxorubicin.
SIOP WT 2001 trial of 583 children, The Lancet, 2015
Neuroblastoma
Neuroblastoma grows from nerve tissue, mainly in the adrenal gland. The international INRG staging system grades localized tumors by image-defined risk factors, features on the scans that make surgery at diagnosis dangerous, such as tumor wrapped around major vessels. In 661 European children, those without these features had 90 percent event-free survival at five years, against 78 percent for those with them, and surgeons give chemotherapy first when they are present.
For high-risk neuroblastoma, the American A3973 analysis of 220 children found that removing at least 90 percent of the primary tumor was linked to better event-free survival, 45.9 against 37.9 percent at five years, and fewer local recurrences, 8.5 against 19.8 percent. Overall survival did not change. Surgeons aim for the most complete removal that is safe, without sacrificing the kidney or major vessels.
Wilms tumor
Wilms tumor leads the kidney cancers of childhood. European SIOP protocols give four weeks of chemotherapy before removing the kidney, which shrinks the tumor and lowers the risk of it rupturing during surgery, while North American protocols remove the kidney first in most children. Both approaches cure most children.
SIOP WT 2001 randomized 583 children with stage II to III intermediate-risk tumors, after surgery, to chemotherapy with or without doxorubicin, a drug that can damage the heart. Event-free survival at two years reached 92.6 against 88.2 percent, within the agreed margin, and five-year survival was 96.5 against 95.8 percent. Heart effects occurred in 5 percent of children given doxorubicin. Doctors dropped the drug for this group.
- The whole kidney is removed with the tumor, the surrounding fat and nearby lymph nodes for staging.
- The other kidney gets a careful look.
- Avoiding rupture of the tumor is a priority, since spillage raises the stage and the need for radiotherapy.
1
Preparation
Blood tests, a central line for chemotherapy if not already in place, and a meeting with the anesthetist and surgeon.
2
The operation
Under general anesthesia with an epidural or nerve block for pain, through an abdominal or chest incision, or by keyhole surgery for selected small tumors. Three to six hours for most.
3
After surgery
One to two days of close monitoring, then the ward. Feeding returns within days. Home follows after five to ten days.
Complications
Bleeding, injury to nearby organs or vessels, and infection are the main early risks. Later, adhesions sometimes block the bowel. Across 1,910 children in the American NWTS-3 study, bowel obstruction after Wilms tumor surgery occurred in 6.9 percent, more frequently after larger tumors, involvement of the large veins or removal of other organs at the same time. Radiotherapy did not add to the risk.
Warning signs after surgery
Vomiting, especially green vomit, a swollen painful abdomen, no stool or wind, fever, or bleeding from the wound need the surgical team the same day, even months after the operation, since adhesions can block the bowel at any time.
If the tumor comes back
Relapse still leaves room for cure. Children in the NWTS-5 study whose Wilms tumor recurred after treatment with two drugs and no radiotherapy were treated again with surgery where feasible, radiotherapy and stronger chemotherapy, and 81.8 percent were alive four years later.
1
First year
Scans every few months and blood tests, with the oncologist leading follow-up.
2
Years two to five
Less frequent scans as the risk of relapse falls.
3
Long term
Checks for late effects of treatment on the heart, kidneys, hearing, growth and fertility, depending on the drugs and radiotherapy used.
Recovery
Children recover faster than adults. Most walk on the first or second day, eat within a few days and return to play within weeks, and the change from a pale, tired child on the ward to one running down the hotel corridor a week later surprises many parents. Chemotherapy restarts two to three weeks after surgery.
Most families stay two to three weeks.
This table scrolls sideways on a narrow screen. Swipe or drag to see every column.
Time in Istanbul
| Stage |
Duration |
| Assessment and tumor board |
Three to five days |
| Surgery and hospital stay |
Five to ten days |
| Recovery before flying |
One week |
Days, cost and the trip
Plan two to three weeks in Istanbul for the operation. The team coordinates chemotherapy and radiotherapy with your home oncologists, so that much of the treatment can continue closer to home. Children can fly once the wound has healed, they eat and walk well and their blood counts are safe, a week after leaving hospital for most children. Cost depends on the tests, the operation, intensive care and the hospital stay. Your own figure follows the free review of your file.
One coordinator arranges the visa invitation letter ten days ahead, the transfer and an apartment near the hospital for the family. A parent stays with the child throughout, play specialists and teachers help long stays pass, and the team works in seven languages with halal meals and a prayer room available. Back home, the surgical and oncology teams review scans and reports sent by your local doctors and stay reachable on the same WhatsApp number. Before you leave, the surgeon writes a full operation note and the pathologist a detailed report of the tumor and its margins, which your local oncologist needs to choose the right chemotherapy and decide on radiotherapy, and the team agrees the dates of the next scans with you so that follow-up continues without gaps, whether the child is treated at home or returns to Istanbul for reviews.
Pediatric tumor resection FAQ
Why is chemotherapy given before surgery in many children?
It shrinks many childhood tumors quickly, which makes the operation safer, lowers the risk of tumor rupture and preserves healthy tissue.
What is the survival rate for Wilms tumor?
In the SIOP WT 2001 trial, 96 percent of children with intermediate-risk stage II to III tumors were alive five years later.
Does the whole tumor have to be removed in neuroblastoma?
Surgeons aim for the most complete removal that is safe. In high-risk disease, removing at least 90 percent was linked to fewer local recurrences.
Can keyhole surgery be used for childhood tumors?
For selected small tumors, yes. Larger tumors or those around major vessels need open surgery.
How long will we stay in Istanbul?
Two to three weeks for the operation, with chemotherapy coordinated with your home team where possible.
Can a parent stay with the child?
Yes. A parent stays with the child throughout the hospital stay.
References
- Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. Journal of Clinical Oncology. 2009;27(2):298-303.
- von Allmen D, Davidoff AM, London WB, et al. Impact of Extent of Resection on Local Control and Survival in Patients From the COG A3973 Study With High-Risk Neuroblastoma. Journal of Clinical Oncology. 2017;35(2):208-216.
- Pritchard-Jones K, Bergeron C, de Camargo B, et al. Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial. Lancet. 2015;386(9999):1156-1164.
- Ritchey ML, Kelalis PP, Etzioni R, Breslow N, et al. Small bowel obstruction after nephrectomy for Wilms' tumor. A report of the National Wilms' Tumor Study-3. Annals of Surgery. 1993;218(5):654-659.
- Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group. Pediatric Blood and Cancer. 2007;48(5):493-499.